Blog
Beyond the First Step: What’s Next for COVID-19 Research
COVID-19 has sped up the process in terms of generating new kinds of vaccines and developing ways to gather real-world data. Read more about how this…
All Results
Blog
White Paper
Synthetic Control Arms: Considerations Around Definition, Drivers, and Design
Those that work in the biopharmaceutical or device industry are likely familiar with the term synthetic controls. But what exactly are synthetic…
Page
Join PRA in China
The expertise of a global CRO + local know-how to deliver the highest caliber of clinical development services around the world.
Page
Join PRA in China 加入 PRA
PRA 重视、尊重和支持他人，践行 “以人为本”。欢迎与我们联系，了解加入PRA中国，一个目前已拥有 500 余名员工的团队。
Webinar
THE INSIGHT SERIES: Why do prescribers participate? - Part III
While Phase II-III studies include small datasets, comprising several hundred to several thousand patients, they provide the data necessary for drug…
Webinar
THE INSIGHT SERIES: Do Late Phase Studies Offer Any Scientific Value? – Part 2
The growing focus on post-marketing and observational research has brought a heightened awareness, and scrutiny, on the design and execution of these…
Webinar
THE INSIGHT SERIES: Introduction to Myths and Misconceptions of Late Phase – Part 1
Late phase research has changed substantially over the past decade. During this period of innovation and development, many myths and misconceptions…
Webinar
THE INSIGHT SERIES: Can you use the same outsourcing methodologies for post-marketing studies as pre-approval research? - Part 4
As the number of preferred provider relationships grow and become more sophisticated, budget grids and assumptions must align with the needs of…
Webinar
THE INSIGHT SERIES: Is there any way to expedite the start-up processes for global non-interventional research? - Part 5
When new drugs are approved, the marketing authorization holders often have to commit themselves to perform additional post-authorization studies.…
Case Study
Challenging Study Timeline Goals Achieved in Global Post-Authorization Safety Study (PASS)
PRA Health Sciences Late Phase Services is participating in a global real world safety study program, mandated by various regulatory bodies, to…